According to DelveInsight's analysis, the current developmental pipeline for osteoarthritis is robust, with several companies initiating clinical trials to investigate new treatment options or improve ...

OKLAHOMA CITY — As Game 1 of the NBA Finals began at Paycom Center, discerning fans on social media asked: “Why aren’t there NBA Finals logos on the court?” For the most part – there are ...

MIAMI--(BUSINESS WIRE)-- Summit Therapeutics Inc. (SMMT) ("Summit," "we," or the "Company") today announced the grant of inducement awards of options to purchase a collective total of up to 71,275 ...

Shares of Tempest Therapeutics rose after the company said its executive team has transitioned into consulting agreements as it continues to explore strategic alternatives. The stock rose 6.6% to ...

Summit Therapeutics Inc. is a biopharmaceutical oncology company focused on the discovery, development, and commercialization of patient-, physician-, caregiver- and societal-friendly medicinal ...

This ELISA-like, antibody-based test allows reliable detection of specific grass pollen allergoids without animal testing, enhancing quality control and supporting standardization of allergy ...

Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Want to stay on top ...

In 2013, two years after leaving Pfizer, Kindler became CEO of Centrexion Therapeutics, a Boston-based company focused on using non-opioid products to ease chronic pain. Kindler still holds the ...

Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit,” “we,” or the “Company”) today announced that it will participate in and present at the 46th Annual Goldman Sachs Global Healthcare ...

BOSTON, June 5, 2025 /PRNewswire/ -- Mediar Therapeutics, Inc., a clinical-stage biotechnology company advancing first-in-class therapies designed to halt fibrosis, today announced the first ...

In its first-quarter 2025 investor letter, Meridian Growth Fund highlighted stocks such as Halozyme Therapeutics, Inc. (NASDAQ:HALO). Based in San Diego, California, Halozyme Therapeutics ...